College of Medicine

Medicine & Life Sciences

1. Alzheimer Disease 28%
2. Anti-Inflammatory Agents 24%
3. Apoptosis 33%
4. Asthma 29%
5. Atrial Fibrillation 37%
6. Biomarkers 28%
7. Biopsy 23%
8. Blood Pressure 33%
9. Blood Vessels 25%
10. Body Mass Index 31%
11. Bone and Bones 32%
12. Brain 43%
13. Breast 40%
14. Breast Neoplasms 70%
15. Carcinoma 23%
16. Chemoradiotherapy 26%
17. Child 41%
18. Chronic Obstructive Pulmonary Disease 41%
19. Cognitive Dysfunction 30%
20. Cohort Studies 61%
21. Colonoscopy 23%
22. Colorectal Neoplasms 33%
23. Confidence Intervals 75%
24. Control Groups 23%
25. Drug Therapy 39%
26. Elderly 42%
27. Endothelial Cells 29%
28. Fluorodeoxyglucose F18 24%
29. Genes 53%
30. Genotype 25%
31. Growth 23%
32. Guidelines 34%
33. Health 25%
34. Hemorrhage 22%
35. Hepatocellular Carcinoma 45%
36. Hip 23%
37. Hypertension 29%
38. Incidence 41%
39. Infections 26%
40. Inflammation 26%
41. Injections 24%
42. Kidney 52%
43. Knee 25%
44. Knee Replacement Arthroplasties 23%
45. Lipopolysaccharides 23%
46. Liver 39%
47. Liver Transplantation 23%
48. Lung 49%
49. Lymph Nodes 36%
50. Magnetic Resonance Imaging 36%
51. Mesenchymal Stem Cells 41%
52. Messenger RNA 25%
53. Meta-Analysis 40%
54. Metabolic Syndrome 27%
55. Mortality 47%
56. Mothers 23%
57. Multicenter Studies 77%
58. Multivariate Analysis 24%
59. Mutation 42%
60. Neoplasm Metastasis 46%
61. Neoplasms 100%
62. Non-Small Cell Lung Carcinoma 28%
63. Nutrition Surveys 28%
64. Obesity 24%
65. Odds Ratio 56%
66. Pain 31%
67. Palatine Tonsil 38%
68. Parkinson Disease 25%
69. Phosphorylation 29%
70. Population 63%
71. Pregnancy 24%
72. Prospective Studies 41%
73. Proteins 33%
74. Radiotherapy 38%
75. Randomized Controlled Trials 30%
76. Recurrence 60%
77. Registries 27%
78. Regression Analysis 25%
79. Retrospective Studies 40%
80. Robotics 23%
81. Safety 51%
82. Seoul 32%
83. Serogroup 23%
84. Serum 51%
85. Shoulder 29%
86. Single Nucleotide Polymorphism 27%
87. Skin 32%
88. Stomach 25%
89. Stomach Neoplasms 43%
90. Stroke 48%
91. Survival 74%
92. Survival Rate 27%
93. Therapeutics 81%
94. Thigh 22%
95. Tomography 50%
96. Transplants 28%
97. Ultrasonography 24%
98. Uric Acid 28%
99. Uterine Cervical Neoplasms 26%
100. Wounds and Injuries 35%